Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0376358 (
prostate cancer
)
59,338
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The NKX3-1 gene is a homeobox gene required for prostate tumor progression, but how it functions is unclear. Here, using chromatin immunoprecipitation coupled to massively parallel sequencing (ChIP-seq) we showed that NKX3-1 colocalizes with the androgen receptor (AR) across the
prostate cancer
genome. We uncovered two distinct mechanisms by which NKX3-1 controls the AR transcriptional network in
prostate cancer
. First, NKX3-1 and AR directly regulate each other in a feed-forward regulatory loop. Second, NKX3-1 collaborates with AR and FoxA1 to mediate genes in advanced and recurrent prostate carcinoma. NKX3-1- and AR-coregulated genes include those found in the "protein trafficking" process, which integrates oncogenic signaling pathways. Moreover, we demonstrate that NKX3-1, AR, and FoxA1 promote
prostate cancer
cell survival by directly upregulating
RAB3B
, a member of the RAB GTPase family. Finally, we show that
RAB3B
is overexpressed in
prostate cancer
patients, suggesting that
RAB3B
together with AR, FoxA1, and NKX3-1 are important regulators of
prostate cancer
progression. Collectively, our work highlights a novel hierarchical transcriptional regulatory network between NKX3-1, AR, and the RAB GTPase signaling pathway that is critical for the genetic-molecular-phenotypic paradigm in androgen-dependent
prostate cancer
.
...
PMID:Integration of regulatory networks by NKX3-1 promotes androgen-dependent prostate cancer survival. 2208 57